Truist lowered the firm’s price target on Inspire Medical (INSP) to $235 from $250 and keeps a Buy rating on the shares. The company’s Q4 ...
Wells Fargo lowered the firm’s price target on Inspire Medical (INSP) to $195 from $198 and keeps an Equal Weight rating on the shares. On ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results